chr1-1535428-G-A
Variant names:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001114748.2(TMEM240):c.453C>T(p.Ala151Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00594 in 1,549,496 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0070 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0058 ( 45 hom. )
Consequence
TMEM240
NM_001114748.2 synonymous
NM_001114748.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.293
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 1-1535428-G-A is Benign according to our data. Variant chr1-1535428-G-A is described in ClinVar as [Benign]. Clinvar id is 593226.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-1535428-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.293 with no splicing effect.
BS2
High AC in GnomAd4 at 1070 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00704 AC: 1070AN: 151968Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
1070
AN:
151968
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00416 AC: 615AN: 147878Hom.: 2 AF XY: 0.00423 AC XY: 334AN XY: 78988
GnomAD3 exomes
AF:
AC:
615
AN:
147878
Hom.:
AF XY:
AC XY:
334
AN XY:
78988
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00583 AC: 8141AN: 1397420Hom.: 45 Cov.: 33 AF XY: 0.00572 AC XY: 3944AN XY: 689260
GnomAD4 exome
AF:
AC:
8141
AN:
1397420
Hom.:
Cov.:
33
AF XY:
AC XY:
3944
AN XY:
689260
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00704 AC: 1070AN: 152076Hom.: 2 Cov.: 32 AF XY: 0.00682 AC XY: 507AN XY: 74342
GnomAD4 genome
AF:
AC:
1070
AN:
152076
Hom.:
Cov.:
32
AF XY:
AC XY:
507
AN XY:
74342
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
TMEM240: BP4, BP7, BS1, BS2 -
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Oct 08, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not specified Benign:1
Aug 01, 2017
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at